Poseida, Roche to collaborate on allogeneic CAR T-cell therapies for hematologic malignancies

Retrieved on: 2022-08-05 17:37:55

Tags for this article:

Click the tags to see associated articles and topics

Poseida, Roche to collaborate on allogeneic CAR T-cell therapies for hematologic malignancies. View article details on hiswai:

Excerpt

Poseida Therapeutics Inc. entered into a collaboration and license agreement with Roche to develop allogeneic CAR T-cell therapies directed to ...

Article found on: cancerletter.com